Navigation Links
Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
Date:6/28/2009

RICHMOND, Calif., June 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that a key research milestone has been achieved in its Research and License Agreement with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein production purposes using Sangamo's proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. Genentech scientists demonstrated the successful knockout of two preselected genes in a Chinese hamster ovary (CHO) cell line. The milestone achievement triggered a payment from Genentech to Sangamo.

"Achievement of this milestone demonstrates the progress under our agreement with Genentech," said Edward Lanphier, Sangamo's president and chief executive officer. "Our ZFN technology is currently being used by major players in pharmaceutical protein production to streamline the process of cell line production, increase the yield and improve the characteristics of biologic drugs, such as antibodies, that are manufactured in mammalian cells."

"Our ZFNs provide the gold standard technology for specifically editing target genes in mammalian cells," stated Philip Gregory, D. Phil., Sangamo's vice president of research. "Moreover, the efficiency of this approach obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ability to quickly and selectively knock out multiple genes in the same cell line creates endless possibilities for biopharmaceutical companies to improve their manufacturing capability."

About Sangamo

Sangamo BioSciences, Inc. is focused on researching and developing zinc finger DNA-binding protein (ZFP) technology for therapeutic gene regulation and mo
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
2. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
3. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
4. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
5. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
8. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
9. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
10. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
11. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... NEW YORK, December 16 ... the publication of GFT505 (80 mg/day),data ... 50 internationally,recognized expert scientists and clinicians ... the continuing role of generic lipid-modifying,treatments, ... which is commonly observed in patients ...
(Date:12/16/2009)... RealMed has been ranked the #1 Claims ... Top 20 Best in KLAS Awards: Software ... a dynamic revenue cycle management solution providing ... providers and all payers. KLAS ... vendor performance measurement in the software, professional ...
(Date:12/16/2009)... 16 According to Millennium Research Group ... intelligence, health care reforms in China supported rapid ... 2009, and will continue to fuel growth in ... Pacific Markets for Interventional Cardiology Devices 2010 ... government will allow the Chinese drug-eluting stent market ...
Breaking Medicine Technology:International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 1Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 2Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 3Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 4Healthcare Debate 3A One Citizens Call for Calm Catches On 56077 1Healthcare Debate 3A One Citizens Call for Calm Catches On 56077 2Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 1Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 2Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 3
... Romark Laboratories, L.C., a,privately-owned biotechnology company, today announced ... the D.E. Shaw Group., The proceeds from ... its lead compound, nitazoxanide, for the treatment of,hepatitis ... for,the treatment of hepatitis B and C and ...
... to report the,publication of important new research results ... Company,s proprietary compounds. FASgen is a leader in,the ... acid synthase,(FASi), and has conducted extensive research in ... treatment of obesity and fatty,liver disease. The Company ...
Other Medicine Technology:FASgen Announces a New Discovery in Obesity Research 2
(Date:12/17/2009)... communications functions were determining factors. StaffKnex, developers of web-based ... was selected by Lifespace Communities to deliver its software ... ... Cleveland, OH (PRWEB) December ... web-based nurse scheduling and employee communication software, recently announced ...
(Date:12/17/2009)... MediNiche provide alternative natural relief prior to considering drugs. ... ... 17, 2009 -- D-Psoria products are the first ... with severe skin conditions . Developed by Astrel ... MediNiche Pharmaceuticals, St. Louis, Missouri., , ,D-Psoria products ...
(Date:12/17/2009)... Therapy or NSRTSM is found very effective in the alleviation ... asthma, migraines, chronic fatigue and a wide array of skin ... using this holistic therapy including over 50 branded BioVeda Health ... ... PA (Vocus) December 16, 2009 -- BioVeda Health and Wellness ...
(Date:12/17/2009)... law firm, litigators of complex personal injury and insurance cases, recognized ... ... Tulsa, OK (Lexis Nexis) December 17, 2009 -- Jody ... of experience handling personal injury and insurance coverage disputes, has been ... attorneys in the state of Oklahoma for 2009-2010., , ,Only five ...
(Date:12/17/2009)... to Utah’s Primary Children’s Hospital from nearby hot tub company ... injury , ... Salt Lake City, ... proud to announce the donation of a Bullfrog Spa to ... in Salt Lake City, Utah. Primary Children’s Medical Center, serving ...
Breaking Medicine News(10 mins):Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 3Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 2Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 3Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 4Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 5Health News:Jody Nathan, Highly Regarded Tulsa Attorney, Named to 2009 Oklahoma Super Lawyers List 2Health News:Bullfrog Spas Helps Critically Ill Children 2Health News:Bullfrog Spas Helps Critically Ill Children 3Health News:Bullfrog Spas Helps Critically Ill Children 4
... of the Journal of the National Cancer Institute says that ... to repair the chromosomal damage caused to the skin and ... squamous cell carcinoma. ,UV radiation is the commonest ... strands in exposed skin cells. Patients who have a condition ...
... may have been triggered by poisonous volcanic gas which erupted ... a new research. This must have happened before dinosaurs came ... of amphibians and reptiles were wiped out. ,Possibilities ... earth, or a greenhouse effect were contemplated by scientists as ...
... press release Priya Ranjan Dasmunsi, Information and Broadcasting Minister said ... dollar scheme to join the International Agency// for Research on ... improve cancer treatments in the country. This membership will help ... us recognize the environmental risk factors and facilitate the development ...
... before voting had an impact on their voting decision. Reports ... that the fear of death// had an impact on the ... of death caused by Osama bin laden tape before the ... voters which made them vote in favor George W. Bush, ...
... now established that consumption of at least five portions ... and citrus fruits can cut the pancreatic risk by ... interview conducted among 532 pancreatic cancer patients and 1, ... the Cancer, Epidemiology, Biomarkers and Prevention journal. ,More ...
... and her team from University of Illinois have found ... abuse during their childhood. Eating disorder develops in women ... stage of their life. The researchers have published the ... Psychology. ,The Research team conducted the survey ...
Other Medicine News:Health News:Poisonous Gas Caused Mass Extinction 2
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: